BTNL2 and myeloid sarcoma: In the case of BTNL2, for example, we were able to include two opposite risk alleles in the network analysis; based on the risk profiles of variants 28 and 100 (rs2076530 and rs3129953, respectively, Table 1) we were able to identify a set of haplotypes that should confer increased risk for ATD (they carry 2 predisposing alleles) and a group of haplotypes that predispose to MS (again with two risk alleles) (Figure 7A).